1. Home
  2. EOLS vs SPTN Comparison

EOLS vs SPTN Comparison

Compare EOLS & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • SPTN
  • Stock Information
  • Founded
  • EOLS 2012
  • SPTN 1917
  • Country
  • EOLS United States
  • SPTN United States
  • Employees
  • EOLS N/A
  • SPTN N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • EOLS Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • EOLS Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • EOLS 589.3M
  • SPTN 596.4M
  • IPO Year
  • EOLS 2018
  • SPTN N/A
  • Fundamental
  • Price
  • EOLS $9.53
  • SPTN $26.54
  • Analyst Decision
  • EOLS Strong Buy
  • SPTN Hold
  • Analyst Count
  • EOLS 5
  • SPTN 1
  • Target Price
  • EOLS $23.75
  • SPTN $26.90
  • AVG Volume (30 Days)
  • EOLS 889.3K
  • SPTN 830.9K
  • Earning Date
  • EOLS 08-05-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • EOLS N/A
  • SPTN 3.28%
  • EPS Growth
  • EOLS N/A
  • SPTN N/A
  • EPS
  • EOLS N/A
  • SPTN N/A
  • Revenue
  • EOLS $275,463,000.00
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • EOLS $33.42
  • SPTN $6.07
  • Revenue Next Year
  • EOLS $33.18
  • SPTN N/A
  • P/E Ratio
  • EOLS N/A
  • SPTN N/A
  • Revenue Growth
  • EOLS 25.38
  • SPTN 0.26
  • 52 Week Low
  • EOLS $8.67
  • SPTN $17.30
  • 52 Week High
  • EOLS $17.82
  • SPTN $26.69
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 51.00
  • SPTN 75.49
  • Support Level
  • EOLS $9.12
  • SPTN $26.37
  • Resistance Level
  • EOLS $10.20
  • SPTN $26.65
  • Average True Range (ATR)
  • EOLS 0.40
  • SPTN 0.09
  • MACD
  • EOLS 0.05
  • SPTN -0.27
  • Stochastic Oscillator
  • EOLS 44.17
  • SPTN 21.05

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: